FDA Approved New 4-Drug Combo for Newly Diagnosed Myeloma Patients | Important Info You Should Know!

Exciting news for newly diagnosed multiple myeloma patients! The US FDA has approved a powerful 4-drug combination therapy for frontline treatment. This video by Dr. Joseph Mikhael, Chief Medical Officer at the International Myeloma Foundation, explains what this means for you.

Key Points:
1. What is the new 4-drug combination therapy?
DARZALEX® (daratumumab)
Velcade® (bortezomib)
REVLIMID® (lenalidomide)
Dexamethasone
2. Why is this FDA approval a big deal for myeloma patients? (Deeper and more durable remissions)
3. Are there any potential downsides to this new treatment? (Managing side effects)
4. What does the future hold for myeloma treatment? (More 4-drug combinations and potentially shorter treatment durations)

This video is essential for anyone with newly diagnosed multiple myeloma, as well as care partners and loved ones seeking to understand the latest treatment options. #knowmyeloma
_______________
Improving Lives | Finding the Cure

Founded in 1990, the International Myeloma Foundation (IMF) is the first and largest organization focusing specifically on multiple myeloma. The IMF’s reach extends to more than 525,000 members in 140 countries worldwide. The IMF is dedicated to improving the quality of lives of myeloma patients while working toward prevention and a cure through our four founding principles: Research, Education, Support, and Advocacy.

Subscribe to our channel:    / imfmyeloma  

Visit our website at: https://www.myeloma.org

Find us online:
Facebook: @myeloma |   / myeloma  
Twitter: @IMFMyeloma |   / imfmyeloma  
Instagram: @imfmyeloma |   / imfmyeloma  
LinkedIn:   / international-myeloma-foundation  

Support the IMF | Donate Now! https://fundraise.myeloma.org/give/52...

Category
Nonprofits & Activism
License
Standard YouTube License

In most cases, captions are autogenerated by YouTube.